Therapeutic targeting of childhood medulloblastoma

The impact of radiation toxicity on quality of life

CDK 4/6 inhibitors: Management of side effects

Survivorship care planning for post-menopausal breast cancer patients in Ireland

What does palbociclib do and what side effects might we see?

Overcoming painful bone disease in myeloma

Benefits and problems of allogeneic stem cell transplantation as multiple myeloma treatment

Editor's ESMO 2016 roundup

Fatigue in men with castration resistant prostate cancer treated with enzalutamide

ESMO 2016 conference highlights

Risk of serious and fatal adverse events with sorafenib use in patients with solid cancers

LUME study of nintedanib finds improved PFS, but no overall survival boost